Research ArticleBehavioral Pharmacology
Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs
Yoji Nagira, Kumiko Goto, Hiroyuki Tanaka, Miwa Aoki, Shingo Furue, Naoki Inagaki, Yasuhiko Tomita and Michitaka Shichijo
Journal of Pharmacology and Experimental Therapeutics May 2016, 357 (2) 273-280; DOI: https://doi.org/10.1124/jpet.115.231225
Yoji Nagira
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Kumiko Goto
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Hiroyuki Tanaka
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Miwa Aoki
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Shingo Furue
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Naoki Inagaki
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Yasuhiko Tomita
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
Michitaka Shichijo
United Graduate School of Drug Discovery and Medical Information Sciences (Y.N., H.T., N.I.), Gifu University, and Laboratory of Pharmacology, Department of Bioactive Molecules (H.T., N.I.), Gifu Pharmaceutical University, Gifu, Japan; Discovery Research Laboratory for Innovative Frontier Medicines (Y.N., K.G., S.F., Y.T., M.S.) and Discovery Research Laboratory for Core Therapeutic Areas (M.A.), Shionogi & Co., Ltd., Toyonaka, Osaka, Japan
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleBehavioral Pharmacology
PGD2 Augment Rhinitis via Neuronal Excitation
Yoji Nagira, Kumiko Goto, Hiroyuki Tanaka, Miwa Aoki, Shingo Furue, Naoki Inagaki, Yasuhiko Tomita and Michitaka Shichijo
Journal of Pharmacology and Experimental Therapeutics May 1, 2016, 357 (2) 273-280; DOI: https://doi.org/10.1124/jpet.115.231225
Research ArticleBehavioral Pharmacology
PGD2 Augment Rhinitis via Neuronal Excitation
Yoji Nagira, Kumiko Goto, Hiroyuki Tanaka, Miwa Aoki, Shingo Furue, Naoki Inagaki, Yasuhiko Tomita and Michitaka Shichijo
Journal of Pharmacology and Experimental Therapeutics May 1, 2016, 357 (2) 273-280; DOI: https://doi.org/10.1124/jpet.115.231225
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement